Linked from

The 30 pages that link to Gout, each with the reason it gives.

• PurineRelated: Excess uric acid, the endpoint of human purine catabolism, can promote gout.

• Uric acidRelated: Excess urate can form crystals that trigger gout attacks.

• Purine metabolismRelated: Excess uric acid from purine breakdown can raise urate levels and promote crystal formation.

• AllopurinolRelated: Long-term allopurinol reduces urate levels to prevent recurrent attacks.

• Thiazide diureticRelated: Thiazide-associated uric acid elevation can precipitate gout in susceptible people.

• HyperuricemiaRelated: It is a common consequence of crystal-forming hyperuricemia, but not inevitable.

• Xanthine oxidaseRelated: Excess uric acid generated through this pathway can promote urate crystal formation.

• FebuxostatRelated: Febuxostat is prescribed to lower urate and reduce crystal formation over time.

• ColchicineRelated: Colchicine treats acute attacks by limiting crystal-triggered inflammatory responses.

• XanthineRelated: Treatments that alter xanthine oxidation can lower uric acid and reduce gout risk.

• PyrazinamideRelated: Pyrazinamide can raise uric acid levels and sometimes trigger gout symptoms.

• InosineRelated: Excess purine degradation can raise uric acid and contribute to gout.

• Gertrude B. ElionRelated: Allopurinol offered a way to prevent attacks by lowering uric acid levels.

• ColchicumRelated: Colchicine is used to treat acute gout flares and prevent them in some patients.

• IndometacinRelated: Indometacin can relieve pain and inflammation during acute gout attacks.

• PolyarthritisRelated: Although often affecting one joint at a time, gout can involve multiple joints.